# Atlas Venture's Biotech Investments: 47 Startups in Its Portfolio (2026) > The 47 Biotech startups Atlas Venture has backed, by stage: $5.5B raised between them. From the rounds we track; updated nightly. Source: https://millionrounds.com/portfolio-maps/atlas-venture-biotech-portfolio (Millionrounds; every figure on the page links to its filing or article) ## Series A 20 - [Dyne Therapeutics](https://millionrounds.com/company/dyne-therapeutics) - [Disc Medicine](https://millionrounds.com/company/disc-medicine) - [Ethyreal Bio](https://millionrounds.com/company/ethyreal-bio) - [*GT* Gemini Therapeutics](https://millionrounds.com/company/gemini-therapeutics) - [Trace Neuroscience](https://millionrounds.com/company/trace-neuroscience) - [*VT* Vima Therapeutics](https://millionrounds.com/company/vima-therapeutics) - [Avrobio](https://millionrounds.com/company/avrobio) - [IFM Therapeutics](https://millionrounds.com/company/ifm-therapeutics) - [Versanis Bio](https://millionrounds.com/company/versanis-bio) - [Synlogic](https://millionrounds.com/company/synlogic) - [*KT* Kyn Therapeutics](https://millionrounds.com/company/kyn-therapeutics) - [Triplet Therapeutics](https://millionrounds.com/company/triplet-therapeutics) - [*A* Arkuda](https://millionrounds.com/company/arkuda) - [Delinia](https://millionrounds.com/company/delinia) - [*AT* Akrevia Therapeutics](https://millionrounds.com/company/akrevia-therapeutics) - [Navitor Pharmaceuticals](https://millionrounds.com/company/navitor-pharmaceuticals) - [Quartet Medicine](https://millionrounds.com/company/quartet-medicine) - [CoStim Pharmaceuticals](https://millionrounds.com/company/costim-pharmaceuticals) - [*L* Lumavita](https://millionrounds.com/company/lumavita) - [Harbour Antibodies](https://millionrounds.com/company/harbour-antibodies) ## Series B 12 - [Kailera Therapeutics](https://millionrounds.com/company/kailera-therapeutics) - [Intellia Therapeutics](https://millionrounds.com/company/intellia-therapeutics) - [Matchpoint Therapeutics](https://millionrounds.com/company/matchpoint-therapeutics) - [Mariana Oncology](https://millionrounds.com/company/mariana-oncology) - [Vigil Neuroscience](https://millionrounds.com/company/vigil-neuroscience) - [Pheon Therapeutics](https://millionrounds.com/company/pheon-therapeutics) - [Bicycle Therapeutics](https://millionrounds.com/company/bicycle-therapeutics) - [*R* Replimune](https://millionrounds.com/company/replimune) - [Nimbus Therapeutics](https://millionrounds.com/company/nimbus-therapeutics) - [Arkuda Therapeutics](https://millionrounds.com/company/arkuda-therapeutics) - [Arrow Therapeutics](https://millionrounds.com/company/arrow-therapeutics) - [*Z* ZappRx](https://millionrounds.com/company/zapprx) ## Series C and later 7 - [Spero Therapeutics](https://millionrounds.com/company/spero-therapeutics) - [Magenta Therapeutics](https://millionrounds.com/company/magenta-therapeutics) - [Sionna Therapeutics](https://millionrounds.com/company/sionna-therapeutics) - [Triveni Bio](https://millionrounds.com/company/triveni-bio) - [Rodin Therapeutics](https://millionrounds.com/company/rodin-therapeutics) - [Momenta Pharmaceuticals](https://millionrounds.com/company/momenta-pharmaceuticals) - [*P* Percardia](https://millionrounds.com/company/percardia) ## Stage not reported 6 - [Remix Therapeutics](https://millionrounds.com/company/remix-therapeutics) - [Ikena Oncology](https://millionrounds.com/company/ikena-oncology) - [Avila Therapeutics](https://millionrounds.com/company/avila-therapeutics) - [*AT* Arteaus Therapeutics](https://millionrounds.com/company/arteaus-therapeutics) - [*RP* Resolvyx Pharmaceuticals](https://millionrounds.com/company/resolvyx-pharmaceuticals) - [Indalo Therapeutics](https://millionrounds.com/company/indalo-therapeutics) ## Pre-seed and seed 2 - [Nvelop Therapeutics](https://millionrounds.com/company/nvelop-therapeutics) - [Renasant Bio](https://millionrounds.com/company/renasant-bio) ## Segment by segment ### Series A 20 startups · $2.2B raised - [**Dyne Therapeutics**](https://millionrounds.com/company/dyne-therapeutics) Dyne Therapeutics is a developer of targeted therapies intended for serious muscle diseases. United States $828M - [**Disc Medicine**](https://millionrounds.com/company/disc-medicine) Disc Medicine is a biopharmaceutical company that develops therapies for hematologic diseases and rare blood disorders. United States $275M - [**Ethyreal Bio**](https://millionrounds.com/company/ethyreal-bio) Ethyreal Bio is a biotechnology startup developing precision therapies for autoimmune thyroid disorders. United States $161M - [*GT* **Gemini Therapeutics**](https://millionrounds.com/company/gemini-therapeutics) Gemini Therapeutics focuses on genetically-defined dry age-related macular degeneration (AMD) and associated rare genetic diseases. United States $138M - [**Trace Neuroscience**](https://millionrounds.com/company/trace-neuroscience) Launched in 2024, Trace Neuroscience is a biopharmaceutical company on a mission to expand the promise of genomic medicine for peo United States $101M - [*VT* **Vima Therapeutics**](https://millionrounds.com/company/vima-therapeutics) United States $100M - [**Avrobio**](https://millionrounds.com/company/avrobio) Avrobio is a clinical stage company developing step-change cell and gene therapies targeting cancer and rare disease. United States $85M - [**IFM Therapeutics**](https://millionrounds.com/company/ifm-therapeutics) IFM Therapeutics is a biopharmaceutical company based in Boston, Massachusetts, focused on developing innovative therapies for can United States $83M ### Series B 12 startups · $2.1B raised - [**Kailera Therapeutics**](https://millionrounds.com/company/kailera-therapeutics) Kailera Therapeutics develops next-generation injectable and oral therapies for chronic weight management. United States $600M - [**Intellia Therapeutics**](https://millionrounds.com/company/intellia-therapeutics) Intellia Therapeutics is a genome editing company that develops curative gene-editing treatments. United States $485M - [**Matchpoint Therapeutics**](https://millionrounds.com/company/matchpoint-therapeutics) Matchpoint Therapeutics is a biotechnology company based in Cambridge, Massachusetts, founded in 2021. United States $220M - [**Mariana Oncology**](https://millionrounds.com/company/mariana-oncology) Mariana Oncology is a biotechnology research industry. United States $175M - [**Vigil Neuroscience**](https://millionrounds.com/company/vigil-neuroscience) Vigil Neuroscience is a biotechnology company that develops novel therapeutics for neurodegenerative diseases. United States $130M - [**Pheon Therapeutics**](https://millionrounds.com/company/pheon-therapeutics) Pheon Therapeutics is a biotechnology company focused on developing next-generation Antibody-Drug Conjugates (ADCs) aimed at treat United Kingdom $120M - [**Bicycle Therapeutics**](https://millionrounds.com/company/bicycle-therapeutics) Bicycle Therapeutics is developing a technology for the creation of new generation biotherapeutics. United Kingdom $110M - [*R* **Replimune**](https://millionrounds.com/company/replimune) United Kingdom $85M ### Series C and later 7 startups · $840M raised - [**Spero Therapeutics**](https://millionrounds.com/company/spero-therapeutics) Spero Therapeutics develops therapeutics for treatment of gram-negative infections. United States $199M - [**Magenta Therapeutics**](https://millionrounds.com/company/magenta-therapeutics) Magenta Therapeutics is a new biotechnology company developing therapeutics that unlock the power of stem cell biology. United States $187M - [**Sionna Therapeutics**](https://millionrounds.com/company/sionna-therapeutics) Sionna Therapeutics is developing novel small molecule therapies to treat cystic fibrosis (CF). United States $182M - [**Triveni Bio**](https://millionrounds.com/company/triveni-bio) Triveni Bio is a clinical-stage biotechnology company based in Watertown, Massachusetts, founded in 2019 through the merger of Ama United States $180M - [**Rodin Therapeutics**](https://millionrounds.com/company/rodin-therapeutics) Rodin Therapeutics develops novel therapeutics for neurological disorders by applying insights of epigenetics. United States $40M - [**Momenta Pharmaceuticals**](https://millionrounds.com/company/momenta-pharmaceuticals) Momenta Pharmaceuticals, Inc. United States $40M - [*P* **Percardia**](https://millionrounds.com/company/percardia) Percardia is a medical device company that develops therapies for the treatment of coronary artery disease. United States $13M ### Stage not reported 6 startups · $191M raised - [**Remix Therapeutics**](https://millionrounds.com/company/remix-therapeutics) Remix Therapeutics is a biotechnology company that is working on developing small molecule medicines. United States $60M - [**Ikena Oncology**](https://millionrounds.com/company/ikena-oncology) Ikena Oncology develops differentiated therapies to target cancer growth and resistance, focusing on Hippo and RAS signaling pathways. United States $40M - [**Avila Therapeutics**](https://millionrounds.com/company/avila-therapeutics) Avila Therapeutics is a biotechnology company focused on the development of covalent drugs to treat cancer and other autoimmune diseases. United States $32M - [*AT* **Arteaus Therapeutics**](https://millionrounds.com/company/arteaus-therapeutics) Arteaus Therapeutics is a biotechnology development company focused on creating new therapies to treat migraine. United States $30M - [*RP* **Resolvyx Pharmaceuticals**](https://millionrounds.com/company/resolvyx-pharmaceuticals) Resolvyx Pharmaceuticals develops therapeutics with small molecule lipid mediators for the treatment of inflammatory diseases. United States $21M - [**Indalo Therapeutics**](https://millionrounds.com/company/indalo-therapeutics) Indalo Therapeutics, Inc. United States $9.0M ### Pre-seed and seed 2 startups · $155M raised - [**Nvelop Therapeutics**](https://millionrounds.com/company/nvelop-therapeutics) Nvelop Therapeutics is a biotechnology company that provides gene editing technology services for unmet major disease needs. United States $100M - [**Renasant Bio**](https://millionrounds.com/company/renasant-bio) Renasant Bio is a biopharmaceutical company based in Berkeley, California, focused on developing oral small molecule therapies for United States $55M **How this map is made.** Every startup here works in Biotech and has raised money in a round we track that names Atlas Venture as an investor. Each sits under the stage of its latest round. Rebuilt nightly; updated 15 November 2026. ## More portfolio maps [All portfolios](https://millionrounds.com/portfolio-maps) [Sector portfolio **Atlas Venture's IT Services portfolio** 18 startups · $337M](https://millionrounds.com/portfolio-maps/atlas-venture-it-services-portfolio)[Co-investors **Who invests with Atlas Venture** 177 co-investors](https://millionrounds.com/portfolio-maps/atlas-venture-co-investors)[Portfolio map **Atlas Venture portfolio map** 132 startups · $11B](https://millionrounds.com/portfolio-maps/atlas-venture-portfolio-map)[Sector portfolio **Techstars' AI portfolio** 336 startups · $4.9B](https://millionrounds.com/portfolio-maps/techstars-ai-portfolio)[Sector portfolio **Alumni Ventures' AI portfolio** 302 startups · $36B](https://millionrounds.com/portfolio-maps/us-strategic-tech-fund-an-alumni-ventures-fund-ai-portfolio)[Sector portfolio **Andreessen Horowitz's AI portfolio** 259 startups · $426B](https://millionrounds.com/portfolio-maps/andreessen-horowitz-ai-portfolio) ## Raising from investors like Atlas Venture? Find the investors who back startups like yours, with their cheques, rounds and partners, in the app with filters, lists and exports. [Find investors](https://millionrounds.com/login?join=1&next=/app/investors)[Market maps](https://millionrounds.com/market-maps)